Welcome to the August edition of the Baker McKenzie Ukraine Healthcare Industry Group Newsletter. This is your regular digest of legal developments affecting the life science and healthcare industries in Ukraine.
This edition covers changes in the regulation of public procurement of pharmaceuticals, including changes that further extend the transition period for procurement based on the National Essential Medicines List, and establishment of the central procurement agency. This edition also covers changes in the list of orphan diseases, the comments of the regulator regarding the format of the conformity assessment body identification number for medical devices and the new requirements on reporting about donations received by healthcare organizations. More details on these developments affecting the Ukrainian life science and healthcare industries are provided below.
In this issue:
- Public procurement of pharmaceuticals
- Orphan diseases
- Medical devices
- Charity and donations